Detecting and Treating HER2 Alterations in Metastatic Colorectal Cancer: Expert and Patient Perspectives

home / around-the-practice / detecting-and-treating-her2-alterations-in-metastatic-colorectal-cancer-expert-and-patient

Elle Charnisky, a patient with stage IV HER2+ metastatic colorectal cancer (mCRC), joins a panel of healthcare professionals to discuss how HER2 alternations are detected and how patients with HER2+ mCRC are optimally treated to improve outcomes.